Vaccines to fight food pathogens

- Last updated on GMT

Related tags: Vaccine, Escherichia coli

Vaccines to combat a number of foodborne pathogens such as Listeria
could be commercially available in the near future, a breakthrough
which would "greatly enhance human health and wellbeing
worldwide," according to US researchers.

A number of studies this week at the 104th General Meeting of the American Society for Microbiology suggest that the search for a vaccine which could prevent foodborne diseases may be nearing its end.

"Vaccines have been proven to be an effective means of prevention for many infectious diseases, but there are no effective vaccines for most common foodborne diseases,"​ said John Gunn of the Ohio State University, who presented research on a new vaccine against multiple bacteria.

"The development of a single vaccine that provides protection against the most common foodborne pathogens would greatly enhance human health,"​ he added.

Gunn and his colleagues have developed a strategy using a live, crippled strain of Salmonella bacteria that do not cause disease to which are added 'pieces' of other bacterial pathogens to stimulate immunity to multiple pathogens.

"We have already developed a highly attenuated Salmonella typhimurium strain which functions as an effective live, oral vaccine against S. typhimurium,"​ he said.

The researchers modified the vaccine strain so that it also contained a gene from another foodborne pathogen, Listeria monocytogenes​. When they administered the modified oral vaccine to mice, it protected them 100 per cent against lethal doses of both foodborne bacteria.

Another group of researchers at the meeting announced they were one step closer toward the development of an edible vaccine against the most virulent forms of the Escherichia coli​ bacteria, known as shiga toxin-producing E. coli, which include the destructive E. coli O157:H7.

These bacteria, because of the shiga toxin they produce, can cause mild to bloody diarrhoea and in some cases are responsible for a complication known as hemolytic uremic syndrome, which is characterised by kidney failure, brain damage and sometimes death.

Sharon Wen and her colleagues at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, successfully transferred a modified version of one of the shiga toxin genes into tobacco plants. This plant-derived vaccine was effective in producing antibodies against the toxin when administered to mice.

"Next the immunised mice will be challenged with the toxin or toxin-producing bacteria to determine if the plant vaccine is protective,"​ said Wen. "Once the protective efficacy of these plant-based vaccines is established, the bacterial genes can then be moved into other plants such as bananas or corn for delivery to humans or animals."

Related topics: Ingredients

Related products

show more

A Baker’s Hero: Vital Wheat Gluten

A Baker’s Hero: Vital Wheat Gluten

Cargill | 25-Oct-2022 | Technical / White Paper

From formulation to finished product, vital wheat gluten is a true superhero when it comes to the bakery. Learn how this humble, plant-based protein rose...

Enhance the shelf life of baked goods now!

Enhance the shelf life of baked goods now!

Mane Kancor Ingredients Pvt. Ltd. | 19-Oct-2022 | Technical / White Paper

Fats in baked foods influence its softness and flavour, however it is also prone to acceleration of oxidation under high temperatures leading to rancidity...

Sugar reduction and alternatives guide

Sugar reduction and alternatives guide

Cambridge Commodities | 28-Sep-2022 | Product Brochure

Cambridge Commodities has selected a number of sugar alternatives including food-based alternative sweetening products, sweeteners of natural origin, and...

We offer even more reason to indulge.

We offer even more reason to indulge.

ADM | 22-Sep-2022 | Insight Guide

Consumers want snacks that are both delicious and nutritious. That’s why we incorporate more fiber and plant-based choices and use ingredients like botanical...

Follow us


View more